Seminar: The challenges of regulating ‘big pharma’
Emily Jackson from Department of Law, London School of Economics
19th May 2011
At 16:00 in Room 6.345, Colchester Campus and afterwards in the Sociology Common Room.
Abstract: It is important to recognise that the way in which companies behave is shaped, at least in part, by the regulatory framework within which they operate. This presentation will focus on a number of criticisms that have been made of the pharmaceutical industry, and will examine the role of regulation as an enabler or facilitator of undesirable, as well as desirable practices.
Emily Jackson is a Professor of Law at the London School of Economics and Deputy Chair of the Human Fertilisation and Embryology Authority. She is also a member of the British Medical Association Medical Ethics Committee, and the Ethics Committees of the Royal College of Physicians and the Royal College of Pathologists.
Her research interests focus on medical law and ethics. In recent years, she has been especially interested in reproductive issues, such as the regulation of assisted conception and embryonic stem cell research, and end of life decision-making.
She is currently writing a book on the regulation of the pharmaceutical industry, due to be published by Hart later this year.